- Home
- SLRX vs ECPG Comparison
SLRX vs ECPG Comparison
Compare SLRX & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRX
- ECPG
- Stock Information
- Founded
- SLRX N/A
- ECPG 1998
- Country
- SLRX United States
- ECPG United States
- Employees
- SLRX N/A
- ECPG N/A
- Industry
- SLRX Biotechnology: Pharmaceutical Preparations
- ECPG Finance Companies
- Sector
- SLRX Health Care
- ECPG Finance
- Exchange
- SLRX Nasdaq
- ECPG Nasdaq
- Market Cap
- SLRX 1.8M
- ECPG 806.1M
- IPO Year
- SLRX N/A
- ECPG 1999
- Fundamental
- Price
- SLRX $0.89
- ECPG $41.17
- Analyst Decision
- SLRX
- ECPG Strong Buy
- Analyst Count
- SLRX 0
- ECPG 3
- Target Price
- SLRX N/A
- ECPG $62.67
- AVG Volume (30 Days)
- SLRX 3.5M
- ECPG 262.2K
- Earning Date
- SLRX 08-08-2025
- ECPG 08-06-2025
- Dividend Yield
- SLRX N/A
- ECPG N/A
- EPS Growth
- SLRX N/A
- ECPG N/A
- EPS
- SLRX N/A
- ECPG N/A
- Revenue
- SLRX N/A
- ECPG $1,380,750,000.00
- Revenue This Year
- SLRX N/A
- ECPG $21.70
- Revenue Next Year
- SLRX N/A
- ECPG $8.86
- P/E Ratio
- SLRX N/A
- ECPG N/A
- Revenue Growth
- SLRX N/A
- ECPG 11.49
- 52 Week Low
- SLRX $0.45
- ECPG $26.45
- 52 Week High
- SLRX $7.20
- ECPG $51.77
- Technical
- Relative Strength Index (RSI)
- SLRX 49.85
- ECPG 63.36
- Support Level
- SLRX $0.86
- ECPG $38.37
- Resistance Level
- SLRX $1.33
- ECPG $39.86
- Average True Range (ATR)
- SLRX 0.14
- ECPG 1.04
- MACD
- SLRX -0.01
- ECPG 0.17
- Stochastic Oscillator
- SLRX 38.70
- ECPG 94.97
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
About ECPG Encore Capital Group Inc
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.